LH
Labcorp Holdings Inc. · Healthcare
Insiders sold $10.1M of Labcorp Holdings Inc. in the last 12 months and bought none
LH over the last year
LH after insider buys
3 months after each buy, from the first price a copier could get.
1 buy has 3 months of prices so far. A record shows here at 3.
Congress
Members reported 46 trades in LH since 2023.
Every filing
142 insider filings since 2016, newest first
Kerrii B Anderson · Director
Adam H Schechter · President and CEO
Amy B. Summy · EVP and Chief Marketing Officer
Peter J Wilkinson · SVP and Chief Accounting Officer
Kathryn W Kyle · EVP and Chief Legal Officer
Bryan T Vaughn · EVP and President, Diagnostics
Kathryn W Kyle · EVP and Chief Legal Officer
Adam H Schechter · President and CEO
Peter J Wilkinson · SVP and Chief Accounting Officer
Adam H Schechter · President and CEO
Der Vaart Sandra D Van · EVP, Corporate Affairs
Brian J Caveney · EVP, Pres of ED, CMO, CSO
Peter J Wilkinson · SVP and Chief Accounting Officer
Adam H Schechter · President and CEO
Amy B. Summy · EVP and CMO
Der Vaart Sandra D Van · EVP and General Counsel
Adam H Schechter · President and CEO
Kerrii B Anderson · Director
Der Vaart Sandra D Van · EVP and General Counsel
Glenn A Eisenberg · CFO and EVP
Kerrii B Anderson · Director
Lance Berberian · EVP, CIO and CTO
Der Vaart Sandra D Van · EVP and General Counsel
Kerrii B Anderson · Director
Peter J Wilkinson · SVP and Chief Accounting Officer
Mark S Schroeder · EVP, Pres Diagnostics, COO
Amy B. Summy · EVP and CMO
Der Vaart Sandra D Van · EVP and General Counsel
Mark S Schroeder · EVP, Pres Diagnostics, COO
Amy B. Summy · EVP and CMO
Glenn A Eisenberg · CFO and EVP
Jonathan P. Divincenzo · EVP, Pres, Central Labs, Intl
Der Vaart Sandra D Van · EVP and General Counsel
Der Vaart Sandra D Van · EVP and General Counsel
Der Vaart Sandra D Van · EVP and General Counsel
Peter J Wilkinson · SVP and Chief Accounting Officer
Kerrii B Anderson · Director
Der Vaart Sandra D Van · EVP and General Counsel
Paul R Kirchgraber · CEO, Covance Drug Development
Mark S Schroeder · EVP, Pres Diagnostics, COO
Mark S Schroeder · EVP, Pres-Diagnostics Lab
Paul R Kirchgraber · CEO, Covance Drug Development
Mark S Schroeder · EVP, Pres-Diagnostics Lab
Der Vaart Sandra D Van · EVP and General Counsel
Mark S Schroeder · EVP, Pres-Diagnostics Lab
Der Vaart Sandra D Van · EVP and General Counsel
Mark S Schroeder · EVP, Pres-Diagnostics Lab
Mark S Schroeder · EVP, Pres-Diagnostics Lab
Glenn A Eisenberg · CFO and EVP
Glenn A Eisenberg · CFO and EVP
About Labcorp Holdings Inc.
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations. In addition, the company offers digital pathology solutions, a pathology platforms that support the digitization, centralized review, and sharing of pathology slides; provider and payer digital platforms, an online applications for providers, MCOs, and ACOs; online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; and Generative AI-enabled Test Selection, a generative AI-enabled tool. It serves clients, third party, medicare/medicaid, patients, pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs. The company has a strategic collaboration with the Children's Hospital of Philadelphia to accelerate the discovery, development, and availability of pediatric diagnostics. It also has a collaboration with Alliance for Clinical Trials in Oncology to advance national clinical trial for patients diagnosed with colorectal cancer. The company was founded in 1995 and is headquartered in Burlington, North Carolina.
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.